Abstract

This research aims to determine the effect of transfer pricing and sales growth on tax avoidance with the COVID-19 pandemic as a moderating variable in healthcare sector companies listed on the IDX in 2018-2022. This research was conducted based on information obtained on the Indonesian Stock Exchange. The sampling technique for this research uses a purposive sampling method. The population in this study were 30 healthcare sector companies listed on the IDX in 2018-2022, and the sample used was ten companies. The data types used are secondary and panel data with regression data analysis techniques and the Moderate Regression Analysis (MRA) test with the EViews 10 analysis tool. This research shows that transfer pricing has a positive and significant effect on tax avoidance, and sales growth has a positive and significant effect on tax avoidance. The COVID-19 pandemic was able to positively moderate (strengthen) the influence of transfer pricing on tax avoidance, and the COVID-19 pandemic was able to negatively moderate (weaken) the influence of sales growth on tax avoidance. Keywords: transfer pricing, sales growth, tax avoidance, COVID-19 pandemic, healthcare sector

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call